← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Synageva Biopharma Corporation
Waltham, MA
$3,201,791
Total funding
8
Grants
Funding over time
peak $755.8K · FY2005–11$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$3,201,791 · 8
By mechanism
R44$2,845,591 · 4
R43$356,200 · 4
Investigators at Synageva Biopharma Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Avian transgenesis via site-directed integration$409,427
R44 · FY2005 · GM
Oviduct locus BACs for expression of bio-therapeutics$381,895
R44 · FY2004 · GM
Enhancement of the glycosylation machinery of the hen bioreactor$377,553
R44 · FY2010 · GM
Enhancement of the glycosylation machinery of the hen bioreactor$369,583
R44 · FY2011 · GM
Oviduct locus BACs for expression of bio-therapeutics$346,359
R44 · FY2005 · GM
Avian transgenesis via site-directed integration$336,837
R44 · FY2006 · GM
Producing Humanized Therapeutics in Avian Egg White$313,297
R44 · FY2006 · AI
Producing Humanized Therapeutics in Avian Egg White$310,640
R44 · FY2007 · AI
Enhancement of the glycosylation machinery of the hen bioreactor.$93,012
R43 · FY2008 · GM
Producing humanized therapeutics in quail egg white$91,727
R43 · FY2004 · AI
Avian transgenesis via site-directed integration$90,000
R43 · FY2004 · GM
Ovalbumin locus BACs for expression of biotherapeutics$81,461
R43 · FY2003 · GM